Tornier NV  

(Public, NASDAQ:TRNX)   Watch this stock  
Find more results for TRNX
21.62
+0.35 (1.65%)
Aug 29 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 21.22 - 21.70
52 week 15.17 - 24.35
Open 21.30
Vol / Avg. 91,759.00/152,519.00
Mkt cap 1.06B
P/E     -
Div/yield     -
EPS -0.67
Shares 48.91M
Beta 1.40
Inst. own 95%
Nov 3, 2014
Q3 2014 Tornier NV Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Aug 7, 2014
Q2 2014 Tornier NV Earnings Call
Aug 7, 2014
Q2 2014 Tornier NV Earnings Release
Jun 26, 2014
Tornier NV Annual Shareholder Meeting
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin -12.03% -11.71%
Operating margin -9.16% -8.10%
EBITD margin - 5.22%
Return on average assets -5.98% -5.36%
Return on average equity -8.12% -7.57%
Employees 1,076 -
CDP Score - -

Address

Olivier van Noortstraat 4
SCHIEDAM, 3124 LA
Netherlands
+31-10-4718888 (Phone)
+31-10-4718888 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Tornier N.V. (Tornier) is a global medical device company focused on surgeons that treat musculoskeletal injuries and disorders of the shoulder, elbow, wrist, hand, ankle and foot. Tornier refers to these surgeons as extremity specialists. The Company sells to this extremity specialist customer base a broad line of joint replacement, trauma, sports medicine and biologic products to treat extremity joints. In certain international markets, it also offers joint replacement products for the hip and knee. The Company sells over approximately 100 product lines in approximately 40 countries. The Company�s principal products are organized in four categories: upper extremity joints and trauma, lower extremity joints and trauma, sports medicine and biologics, and large joints and other. The Company�s geographic regions consist of the United States, France and other areas. On October 4, 2012, the Company acquired OrthoHelix.

Officers and directors

David H. Mowry President, Chief Executive Officer
Age: 50
Bio & Compensation  - Reuters
Shawn T. McCormick Chief Financial Officer
Age: 47
Bio & Compensation  - Reuters
Terry M. Rich Senior Vice President - U.S. Commercial Operations
Age: 45
Bio & Compensation  - Reuters
Gordon W. Van Ummersen Senior Vice President of Global Product Delivery
Bio & Compensation  - Reuters
Gregory Morrison Global Vice President - Human Resources
Age: 49
Bio & Compensation  - Reuters
Kevin M. Klemz Vice President, Chief Legal Officer, Secretary
Age: 51
Bio & Compensation  - Reuters
Stephan Epinette Vice President - International Commercial Operations
Bio & Compensation  - Reuters
Sean D. Carney Non-Executive Independent Chairman of the Board
Age: 45
Bio & Compensation  - Reuters
Kevin C. O'Boyle CPA Interim Non-Executive Independent Vice Chairman of the Board
Age: 58
Bio & Compensation  - Reuters
Alain Tornier Non-Executive Director
Age: 66
Bio & Compensation  - Reuters